Genmab — Juli 2018
-
Seattle Genetics Announces First Patient Dosed in Phase 2 innovaTV 207 Trial Evaluating Tisotumab Vedotin in Multiple Solid Tumors - http://investor.seagen.com/phoenix.zhtml?c=124860&p=irol-newsArticle&ID=2357993
-
Unum Therapeutics to Present Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the American Society of Hematology (ASH) Summit on Emerging Immunotherapies for Hematological Diseases https://globenewswire.com/news-release/2018/07/12/1536414/0/en/Unum-Therapeutics-to-Present-Pre-Clinical-Data-on-its-Antibody-Coupled-T-Cell-Receptor-ACTR-Platform-at-the-American-Society-of-Hematology-ASH-Summit-on-Emerging-Immunotherapies-fo.html
-
God morgen
-
God morgen
-
God morgen.
-
-
-
-
http://borsen.dk/nyheder/virksomheder/artikel/1/365701/johnson_johnson_idoemt_kraeft-erstatning_paa_47_mia_dollar.html stor mulighed for yderligere salg af Darzalex - måske de skulle smide lidt frysetørret darzalex i det babypudder, så de på den sikrer side
-
Fredag den 13, vi har fortjent en fredagsnyhed, det er længe siden, vi har haft en
-
i går var torsdag, jeg efterlyste en fredags nyhed
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind